نمایش پرونده ساده آیتم

dc.contributor.authorRezapour, S
dc.contributor.authorBahrami, T
dc.contributor.authorHashemzadeh, S
dc.contributor.authorEstiar, MA
dc.contributor.authorNemati, M
dc.contributor.authorRavanbakhsh, R
dc.contributor.authorFeizi, MAH
dc.contributor.authorKafil, HS
dc.contributor.authorPouladi, N
dc.contributor.authorGhojazadeh, M
dc.contributor.authorSakhinia, E
dc.date.accessioned2018-08-26T09:36:19Z
dc.date.available2018-08-26T09:36:19Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57972
dc.description.abstractBackground: Stanniocalcin-1 (STC1) and nuclear factor (NF)-RB subunit p65 transcription factor are involved in various types of human malignancies. The roles of STC1 and NFRB-p65 in colorectal cancer (CRC) are still not fully understood. We investigated expression levels of NF-RB p65 and STC1 and also correlations between STC1 and NF-RB p65 expression and clinicopathological features in CRC. Methods: Tumor tissue samples were collected from 48 patients with CRC. RT-PCR and Real-time PCR analysis was performed to examine mRNA levels of STC1 and NF-RB p65. Results: The relative mRNA levels of STC1 and NF-RB p65 were significantly higher in tumor tissues than in adjacent mucosa (p = 0.025 and p = 0.044, respectively). The data also showed that STC1 and NF-RB p65 mRNA levels were not significantly associated with clinicopathological characteristics. In addition, there was no association between expression levels of STC1 and NF-RB p65 in tumor samples. Conclusions: Our data indicate that STC1 and NF-KBp65 is activated constitutively in colorectal carcinoma tissues, suggesting that activation of these factors might play an important role in colorectal tumorigenesis. Future studies should examine STC1 and NF-?Bp65 as a molecular target for the treatment of CRC.
dc.language.isoEnglish
dc.relation.ispartofClinical Laboratory
dc.subjecthypocalcin
dc.subjectmessenger RNA
dc.subjectstanniocalcin 1
dc.subjecttranscription factor RelA
dc.subjectunclassified drug
dc.subjectglycoprotein
dc.subjecthypocalcin
dc.subjectmessenger RNA
dc.subjecttranscription factor RelA
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectcancer surgery
dc.subjectclinical article
dc.subjectcolorectal cancer
dc.subjectcontrolled study
dc.subjectfemale
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectmale
dc.subjectmolecular pathology
dc.subjectprotein expression
dc.subjectreal time polymerase chain reaction
dc.subjectreverse transcription polymerase chain reaction
dc.subjectColorectal Neoplasms
dc.subjectgenetics
dc.subjectmetabolism
dc.subjectmiddle aged
dc.subjectpathology
dc.subjectAdult
dc.subjectAged
dc.subjectColorectal Neoplasms
dc.subjectFemale
dc.subjectGlycoproteins
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectRNA, Messenger
dc.subjectTranscription Factor RelA
dc.titleSTC1 and NF-?B p65 (Rel A) is constitutively activated in colorectal cancer
dc.typeReview
dc.citation.volume62
dc.citation.issue3
dc.citation.spage463
dc.citation.epage469
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.7754/Clin.Lab.2015.150827


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم